cd 2019 has been researched along with ro 41-5253 in 1 studies
Studies (cd 2019) | Trials (cd 2019) | Recent Studies (post-2010) (cd 2019) | Studies (ro 41-5253) | Trials (ro 41-5253) | Recent Studies (post-2010) (ro 41-5253) |
---|---|---|---|---|---|
12 | 0 | 2 | 62 | 0 | 14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Y; MacLennan, AJ; Rogers, MB | 1 |
1 other study(ies) available for cd 2019 and ro 41-5253
Article | Year |
---|---|
A putative G-protein-coupled receptor, H218, is down-regulated during the retinoic acid-induced differentiation of F9 embryonal carcinoma cells.
Topics: Animals; Benzoates; Bucladesine; Carcinoma, Embryonal; Cell Differentiation; Chromans; Down-Regulation; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Mice; Naphthalenes; Neoplasm Proteins; Phenotype; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Receptors, Retinoic Acid; Retinoids; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Tetrahydronaphthalenes; Tretinoin; Tumor Cells, Cultured | 1998 |